Loading company…
France-based cell therapy developer focused on regenerative medicine, with its lead program targeting Parkinson's Disease.
Established in 2018 in France and headquartered in Bordeaux, TreeFrog Therapeutics was co-founded by Erwan Bezard and Kévin Alessandri. Its lead product targets Parkinson's Disease using the C-Stem technology platform, and the company is also working on liver disease therapies. A Series B round closed on May 27, 2025, raising EUR 40.645 mn led by Bpifrance.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in